Skip to main content
. 2016 Jan 6;36(1):204–221. doi: 10.1523/JNEUROSCI.1751-15.2016

Table 1.

Two-way ANOVA of the data shown in Figure 1 (MOR KO mice)

Row Figure Experiment n Variable 1 Variable 2 Interaction Subject matching
1 1A MOR KO mice (CFA) WT saline: 3
WT CFA: 9
KO CFA: 8
Time (CFA) Group p < 0.0001 p = 0.001
p < 0.0001 p < 0.0001 F(24,204) = 4.2 F(17,204) = 2.5
F(12,204) = 14.4 F(2,17) = 43.8
2 1A MOR KO mice (baseline) Time Group p = 0.18 p = 0.044
p = 0.43 p = 0.25 F(4,34) = 1.7 F(17,34) = 1.98
F(2,34) = 0.86 F(2,17) = 1.5
3 1B MOR KO mice (NTX) Time (NTX) Group p < 0.0001 p = 0.001
p < 0.0001 p < 0.0001 F(8,64) = 8.4 F(16,64) = 2.58
F(4,64) = 8.35 F(2,16) = 46.8
4 1C MOR KO mice (6β-naltrexol) Time (6β-naltrexol) Group p = 0.80 p < 0.0001
p = 0.17 p = 0.0023 F(8,68) = 0.56 F(17,68) = 21.7
F(4,68) = 1.65 F(2,17) = 8.85
5 1D MOR KO mice (BRL 44408) Time (BRL44408) Group p < 0.0001 p = 0.0265
p < 0.0001 p < 0.0001 F(8,68) = 6.2 F(17,68) = 1.96
F(4,68) = 13.9 F(2,17) = 65.0
6 1E MOR KO mice (naltrindole) Time (naltrindole) Group p = 0.19 p < 0.0001
p < 0.0001 p = 0.0069 F(8,68) = 1.45 F(17,68) = 0.45
F(4,68) = 9.28 F(2,17) = 6.75
7 1F WT mice (naltrindole) WT saline: 6 Time (naltrindole) Group p = 0.11 p = 0.0002
WT CFA: 14 p = 0.0002 p = 0.39 F(4,72) = 2.0 F(18,72) = 3.26
F(4,72) = 14.4 F(1,18) = 0.79

Each panel in Figure 1 (indicated in the second column) was analyzed independently by two-way ANOVA. In row 2, “baseline” refers to data obtained before the CFA injection. In the fourth column, n is the number of animals in the experiment. In the fifth and sixth columns, the variable is identified first: “time” refers to the time after the injection of the compound in parentheses; “group” is the animal group according to genotype and treatment. Subscript numbers in the F ratio are the degrees of freedom and the residual.